These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related]
7. Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 and D2 dopamine receptors. Ruskin DN; Bergstrom DA; Walters JR J Pharmacol Exp Ther; 1999 Sep; 290(3):1493-501. PubMed ID: 10454529 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Carlson JH; Bergstrom DA; Walters JR Brain Res; 1987 Jan; 400(2):205-18. PubMed ID: 2880637 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum. Napier TC; Maslowski-Cobuzzi RJ Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198 [TBL] [Abstract][Full Text] [Related]
12. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. Carlson JH; Bergstrom DA; Walters JR Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101 [TBL] [Abstract][Full Text] [Related]
13. Topography of dopamine D-1 and D-2 receptor-mediated rotation after intrastriatal injections of dopamine-related drugs in normosensitive rats. Konitsiotis S; Kafetzopoulos E Eur J Pharmacol; 1990 Apr; 179(1-2):201-5. PubMed ID: 2142084 [TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor regulation of ethanol intake and extracellular dopamine levels in the ventral pallidum of alcohol preferring (P) rats. Melendez RI; Rodd ZA; McBride WJ; Murphy JM Drug Alcohol Depend; 2005 Mar; 77(3):293-301. PubMed ID: 15734229 [TBL] [Abstract][Full Text] [Related]
16. D2 antagonist-induced c-fos in an identified subpopulation of globus pallidus neurons by a direct intrapallidal action. Billings LM; Marshall JF Brain Res; 2003 Feb; 964(2):237-43. PubMed ID: 12576184 [TBL] [Abstract][Full Text] [Related]
17. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine. Heidenreich BA; Mailman RB; Nichols DE; Napier TC J Pharmacol Exp Ther; 1995 Apr; 273(1):516-25. PubMed ID: 7714807 [TBL] [Abstract][Full Text] [Related]
18. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression. Marshall JF; Henry BL; Billings LM; Hoover BR Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604 [TBL] [Abstract][Full Text] [Related]
19. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine. Mereu G; Collu M; Ongini E; Biggio G; Gessa GL Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035 [TBL] [Abstract][Full Text] [Related]
20. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus. Carlson JH; Bergstrom DA; Demo SD; Walters JR Synapse; 1990; 5(2):83-93. PubMed ID: 2309160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]